Genentech Dumps Another $650M in New Haven Biotech Arvinas Post author:Sam Post published:November 14, 2017 Post category:BioPharma Arvinas expanded an ongoing licensing deal with Genentech. Source: BioSpace You Might Also Like Rheos Medicines Launches with $60 Million March 21, 2018 SpinalCyte, LLC Receives New Japanese Patent July 20, 2017 Rumor Alert: AstraZeneca PLC CEO to Become Teva's New Leader July 12, 2017
